To The Moon

Sign Up

ARKG Investment Tracker

Source from：official website ARKG is an exchange-traded fund (ETF) managed by Cathie Wood, focusing on stocks related to the genomic revolution. The "ARK Genomic Revolution Fund Guru Tracker" is based on ARKG's daily disclosure reports, helping investors track its investment strategy.

    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Veeva by 49 shares, the number of shares held decreased 0.79% compared to the previous period and now represents 0.089% of the total position.
      9Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in GeneDx Holdings by 2,268 shares, the number of shares held decreased 0.84% compared to the previous period and now represents 1.97% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Butterfly Network Inc by 52,094 shares, the number of shares held decreased 0.84% compared to the previous period and now represents 1.53% of the total position.
      21Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Schrodinger Inc. by 17,717 shares, the number of shares held decreased 0.84% compared to the previous period and now represents 1.98% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Veracyte by 9,177 shares, the number of shares held decreased 0.84% compared to the previous period and now represents 3.27% of the total position.
      85Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Ionis Pharmaceuticals by 3,360 shares, the number of shares held decreased 0.84% compared to the previous period and now represents 2.84% of the total position.
      0Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in 10x Genomics, Inc. by 27,496 shares, the number of shares held decreased 0.84% compared to the previous period and now represents 5.18% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Nurix Therapeutics by 13,314 shares, the number of shares held decreased 0.84% compared to the previous period and now represents 2.04% of the total position.
      1Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in Twist Bioscience Corp by 17,556 shares, the number of shares held decreased 0.84% compared to the previous period and now represents 8.43% of the total position.
      14Comment
      Report
    • ARKG Investment TrackerARKG Investment Tracker
      ·07:13
      ARKG Investment Tracker position change: Decreased position in CareDx by 17,780 shares, the number of shares held decreased 0.84% compared to the previous period and now represents 3.33% of the total position.
      0Comment
      Report
       
       
       
       

      Most Discussed